title: Subcellular trafficking of the cytoplasmic expression system.
abstract: Cationic liposomes have provided many advantages over viral vector formulations; however, the problem of inefficient gene expression remains. This is due in part to the nuclear membrane, which limits DNA entry into the nucleus. Cytoplasmic expression systems using T7 RNA polymerase have been developed to express genes in the cytoplasm and avoid the need for nuclear import of DNA. Although these systems show improved transgene expression, little is known about how they function in transfected cells. Direct comparisons between a cytoplasmic and nuclear expression system were carried out with a 293 cell line stably expressing T7 RNA polymerase. A formulation for optimal reporter gene expression was developed and used in conjunction with a variety of subcellular trafficking inhibitors to study the process of DNA endocytosis. Transfected cells were also studied at different stages of the cell cycle to determine the dependence of each system on mitosis. These results showed that cytoplasmic and nuclear expression systems utilize similar endocytosis pathways to the point of endosomal release. Once DNA is released into the cytoplasm, the cytoplasmic expression system shows immediate expression that is proportional to the amount of DNA released. In contrast, DNA targeted for nuclear expression requires additional time for nuclear entry. The level of nuclear expression is also restricted by the limited amount of DNA that is imported into the nucleus. Finally, mitosis is required for effective nuclear expression but not for cytoplasmic expression. Therefore, the cytoplasmic expression system has considerable advantages over traditional nuclear expression systems and may be an effective method for transfecting nondividing cells. Efficient expression of genes delivered by nonviral vectors is hindered owing to poor nuclear transport of plasmid DNA. A potential solution to this problem would be to use a cytoplasmic expression system. Previous studies have shown that this method produces enhanced gene expression when compared with traditional nuclear expression systems; however, the actual mechanisms by which the cytoplasmic expression system works remains unknown. This article focuses on a direct comparison between cytoplasmic and nuclear expression in terms of optimal DNA delivery formulations, intracellular trafficking of DNA, and cell cycle dependence. These results indicate that the cytoplasmic expression system has two primary advantages over nuclear expression in that it does not rely on nuclear DNA transport or mitosis for efficient expression.
authors.affiliation: Department of Pharmacology, University of Pittsburgh School of Medicine, PA 15261, USA.
authors.forename: M
authors.initials: M
authors.lastname: Brisson
authors.forename: W C
authors.initials: WC
authors.lastname: Tseng
authors.forename: C
authors.initials: C
authors.lastname: Almonte
authors.forename: S
authors.initials: S
authors.lastname: Watkins
authors.forename: L
authors.initials: L
authors.lastname: Huang
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002411:Cation Exchange Resins / Q000494:pharmacology; D002460:Cell Line / Q000378:metabolism; D002467:Cell Nucleus / Q000235:genetics* / Q000378:metabolism; D002738:Chloroquine / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D003593:Cytoplasm / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D004247:DNA / Q000378:metabolism; D004705:Endocytosis / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000235:genetics / Q000378:metabolism; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology; D005786:Gene Expression Regulation; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000378:metabolism; D008055:Lipids / Q000494:pharmacology; D008081:Liposomes / Q000235:genetics; D008156:Luciferases / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D018942:Macrolides; D008938:Mitosis; D015739:Nocodazole / Q000494:pharmacology; D011401:Promoter Regions, Genetic; D011479:Protamines / Q000378:metabolism; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D013347:Subcellular Fractions
chemical_list: D000900:Anti-Bacterial Agents; D002411:Cation Exchange Resins; D004791:Enzyme Inhibitors; D005229:Fatty Acids, Monounsaturated; D008055:Lipids; C086724:Lipofectamine; D008081:Liposomes; D018942:Macrolides; D011479:Protamines; D000644:Quaternary Ammonium Compounds; C057620:bafilomycin A; D003571:Cytochalasin B; D004815:Epidermal Growth Factor; D002738:Chloroquine; D004247:DNA; D008156:Luciferases; C070046:1,2-dioleoyloxy-3-(trimethylammonium)propane; D015739:Nocodazole